EUVIMEDEUVIMED entdecken
Fallbericht

Successful Treatment of Palmoplantar Psoriasis With Apremilast in an Immunosuppressed Pediatric Patient on Concurrent Biologic Therapy

Shawheen J Rezaei iD, Danny Linggonegoro, Shehla Admani

Pediatric Dermatology · 2025-07 · 42 (4) · 885-887

DOI: 10.1111/pde.15872 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Pediatric Dermatology, online erschienen am 29.01.2025. Verfasst von Shawheen J Rezaei und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Stanford University School of Medicine, Stanford, California, USA. Hauptthemen laut MEDLINE: Psoriasis, Thalidomide, Anti-Inflammatory Agents, Non-Steroidal, Immunocompromised Host. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunosuppressive medication may be indicated in patients with severe psoriasis refractory to other treatment modalities. There is a subset of patients, however, who are immunosuppressed at baseline and are not ideal candidates for these agents. Here we report the case of a 15‐year‐old girl on immunosuppressive medication for preexisting pancolitis and chronic recurrent multifocal osteomyelitis who had an excellent response to concurrent apremilast therapy for her previously refractory palmoplantar psoriasis. These findings support the potential role of apremilast in treating pediatric palmoplantar psoriasis and its utility as an adjunctive therapy in immunosuppressed patients with refractory skin disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisThalidomideAnti-Inflammatory Agents, Non-SteroidalImmunocompromised HostHumansFemaleAdolescentImmunosuppressive Agents

Stichwörter der Autor:innen

apremilastpalmoplantar diseasepediatric psoriasispsoriasis

Substanzen

apremilastThalidomideAnti-Inflammatory Agents, Non-SteroidalImmunosuppressive Agents

Autor:innen und Institutionen

  • Department of Dermatology, Stanford University School of Medicine, Stanford, California, USA.

ORCID-Profile: Shawheen J Rezaei

Zitieren

APA

Rezaei, S. J., Linggonegoro, D., & Admani, S. (2025). Successful Treatment of Palmoplantar Psoriasis With Apremilast in an Immunosuppressed Pediatric Patient on Concurrent Biologic Therapy. Pediatric Dermatology, 42(4), 885-887. https://doi.org/10.1111/pde.15872

Vancouver

Rezaei SJ, Linggonegoro D, Admani S. Successful Treatment of Palmoplantar Psoriasis With Apremilast in an Immunosuppressed Pediatric Patient on Concurrent Biologic Therapy. Pediatric Dermatology. 2025;42(4):885-887. doi:10.1111/pde.15872

BibTeX
@article{Rezaei2025,
  author = {Rezaei, Shawheen J and Linggonegoro, Danny and Admani, Shehla},
  title = {Successful Treatment of Palmoplantar Psoriasis With Apremilast in an Immunosuppressed Pediatric Patient on Concurrent Biologic Therapy},
  journal = {Pediatric Dermatology},
  year = {2025},
  volume = {42},
  number = {4},
  pages = {885--887},
  doi = {10.1111/pde.15872}
}
Kostenlos starten →